Invesco UK Ltd Invesco Ltd: Form 8.3 - Horizon Therapeutics Plc

 
TIDMIRSH 
 

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.      KEY INFORMATION 
 
      (a) Full name of discloser                                        Invesco Ltd. 
----------------------------------------------------------------------  ----------------------- 
      (b) Owner or controller of interests and short positions 
       disclosed, if different from 1(a) 
       The naming of nominee or vehicle companies is insufficient. 
       For a trust, the trustee(s), settlor and beneficiaries 
       must be named. 
----------------------------------------------------------------------  ----------------------- 
      (c) Name of offeror/offeree in relation to whose relevant         Horizon Therapeutics 
       securities this form relates                                     PLC 
       Use a separate form for each offeror/offeree 
----------------------------------------------------------------------  ----------------------- 
      (d) If an exempt fund manager connected with an offeror/offeree, 
       state this and specify identity of offeror/offeree 
       (Note 1) 
----------------------------------------------------------------------  ----------------------- 
      (e) Date position held/dealing undertaken                         01/12/2022 
       For an opening position disclosure, state the latest 
       practicable date prior to the disclosure 
----------------------------------------------------------------------  ----------------------- 
      (f) In addition to the company in 1(c) above, is the              YES 
       discloser also making disclosures in respect of any               If YES, specify which: 
       other party to the offer?                                         Amgen Inc 
       If it is a cash offer or possible cash offer, state 
       "N/A" 
----------------------------------------------------------------------  ----------------------- 
 
   2.      INTERESTS AND SHORT POSITIONS 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2)

 
Class of relevant security 
 (Note 3)                                                   Common Stock IE00BQPVQZ61 
--------------------------------------------------------  ------------------------------ 
                                                                                Short 
                                                              Interests       positions 
--------------------------------------------------------  -----------------  ----------- 
                                                           Number      %     Number   % 
--------------------------------------------------------  ---------  ------  ------  --- 
      (1) Relevant securities owned and/or controlled     3,508,422   1.547 
--------------------------------------------------------  ---------  ------  ------  --- 
      (2) Cash-settled derivatives 
--------------------------------------------------------  ---------  ------  ------  --- 
      (3) Stock-settled derivatives (including options) 
       and agreements to purchase/ sell 
--------------------------------------------------------  ---------  ------  ------  --- 
Total                                                     3,508,422   1.547 
--------------------------------------------------------  ---------  ------  ------  --- 
 

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

   3.      DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4) 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)      Purchases and sales 
 
Class of relevant  Purchase/sale  Number of    Price per unit 
 security                          securities   (Note 5) 
-----------------  -------------  -----------  -------------- 
Common Stock       Purchase       483          100.29 USD 
-----------------  -------------  -----------  -------------- 
Common Stock       Purchase       4            100.22 USD 
-----------------  -------------  -----------  -------------- 
Common Stock       Sale           36           100.29 USD 
-----------------  -------------  -----------  -------------- 
 
   (b)      Cash-settled derivative transactions 
 
Class of   Product       Nature of dealing                                           Number of    Price 
 relevant   description   e.g. opening/ closing a long/ short position, increasing/   reference    per unit 
 security   e.g. CFD      reducing a long/ short position                             securities   (Note 5) 
                                                                                      (Note 6) 
---------  ------------  ----------------------------------------------------------  -----------  --------- 
 
 
   (c)      Stock-settled derivative transactions (including options) 
   (i)      Writing, selling, purchasing or varying 
 
Class of   Product                 Writing, purchasing, selling, varying  Number       Exercise    Type        Expiry  Option 
 relevant   description e.g. call   etc.                                   of           price per   e.g.        date    money 
 security   option                                                         securities   unit        American,           paid/ 
                                                                           to which                 European            received per unit 
                                                                           option                   etc. 
                                                                           relates 
                                                                           (Note 6) 
---------  ----------------------  -------------------------------------  -----------  ----------  ----------  ------  ------------------ 
 
 
   (ii)      Exercise 
 
Class of   Product       Exercising/  Number of    Exercise 
 relevant   description   exercised    securities   price per 
 security   e.g. call     against                   unit 
            option                                  (Note 5) 
---------  ------------  -----------  -----------  ---------- 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 3) 
 
Class of   Nature of dealing      Details  Price per unit (if 
 relevant   e.g. subscription,              applicable) 
 security   conversion, exercise            (Note 5) 
---------  ---------------------  -------  ------------------ 
 
 
   4.      OTHER INFORMATION 
   (a)      Indemnity and other dealing arrangements 
 
Details of any indemnity or option arrangement, 
 or any agreement or understanding, formal 
 or informal, relating to relevant securities 
 which may be an inducement to deal or 
 refrain from dealing entered into by 
 the person making the disclosure and 
 any party to the offer or any person 
 acting in concert with a party to the 
 offer. 
 Irrevocable commitments and letters 
 of intent should not be included. If 
 there are no such agreements, arrangements 
 or understandings, state "none" 
----------------------------------------------- 
 
 
   (b)      Agreements, arrangements or understandings relating to options or derivatives 
 
Full details of any agreement, arrangement 
 or understanding between the person 
 disclosing and any other person relating 
 to the voting rights of any relevant 
 securities under any option referred 
 to on this form or relating to the voting 
 rights or future acquisition or disposal 
 of any relevant securities to which 
 any derivative referred to on this form 
 is referenced. If none, this should 
 be stated. 
------------------------------------------ 
 
 
   (c)        Attachments 
 
Is a Supplemental Form 8 attached?  NO 
---------------------------------- 
 
 
Date of disclosure     02/12/2022 
-------------------  --------------- 
Contact name         Philippa Holmes 
-------------------  --------------- 
Telephone number        01491 417447 
-------------------  --------------- 
 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

(END) Dow Jones Newswires

December 02, 2022 07:04 ET (12:04 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.